Reaction
Hormone-Dependent Prostate Cancer reporting signals
As of the last recalculation, Hormone-Dependent Prostate Cancer appears in 68 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is ABIRATERONE (PRR 592.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Abiraterone | 19 | 592.4 | 593.3 |
| Bicalutamide | 11 | 263.4 | 263.6 |
| Lutetium Lu 177 Vipivotide Tetraxetan | 9 | 240.8 | 241.0 |
| Abiraterone Acetate | 20 | 210.3 | 210.4 |
| Dolutegravir Sodium | 5 | 183.0 | 183.1 |
| Apalutamide | 4 | 110.6 | 110.6 |